Zotepine is a second generation antipsychotic with a primary use as a treatment for schizophrenia, although clinical trials have been conducted (with positive results) into its efficacy as an antimanic agent in patients with acute bipolar mania. References: Chan HY, Lin AS, Chen KP, Cheng JS, Chen YY, Tsai CJ. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation. J Clin Psychopharmacol. 2013 Dec;33(6):747-52. doi: 10.1097/JCP.0b013e31829e8168. PubMed PMID: 24100785.

纯度：≥98%

CAS：26615-21-4